The authors did emphasize that they were not ruling on the overall “clinical efficacy” of hydroxychloroquine with this research. 

Researchers wrote that they observed "substantial and increasing disparities in CVD between people with the most resources and the remainder of the U.S. population."

The latest evidence of COVID-19's cardiovascular impact on patients comes from a new imaging study published in the American Journal of Roentgenology.

The study's authors identified dozens of potential new biomarkers, sharing their findings in the Proceedings of the National Academy of Sciences.

The map, part of a study published in Nature, can provide new details about cellular structure and how cells interact with one another. It could even help with the treatment of COVID-19. 

The transplant, performed at UC San Diego Health, was part of an ongoing clinical trial. 

The Trump Administration’s main aim is widening consumer access to lower prices.